RAS-DIRECTED N-GLYCOPROTEINS ARE NOVEL EARLY BIOMARKERS FOR TUMORIGENESIS AND MALIGNANT TRANSFORMATION AND THERAPEUTIC TARGETS OF NEUROFIBROMATOSIS T

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators